Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Has Average Target Price of $17.20 According to Analysts

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) have been assigned an average rating of “Hold” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $13.00.

SENS has been the topic of several recent research reports. Weiss Ratings raised Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, September 17th. Barclays assumed coverage on Senseonics Holdings, Inc. Common Stock in a research report on Wednesday. They set an “equal weight” rating and a $10.00 price objective for the company. Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a report on Saturday, August 8th. Finally, Mizuho reduced their target price on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th.

Senseonics Holdings, Inc. Common Stock Stock Performance

Senseonics Holdings, Inc. Common Stock stock opened at $9.16 on Thursday. The stock’s 50 day simple moving average is $8.74 and its two-hundred day simple moving average is $7.08. The company has a debt-to-equity ratio of 0.62, a quick ratio of 6.40 and a current ratio of 6.74. The stock has a market cap of $382.89 million, a price-to-earnings ratio of -4.11 and a beta of 1.02. Senseonics Holdings, Inc. Common Stock has a fifty-two week low of $4.79 and a fifty-two week high of $10.64.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.08). The firm had revenue of $14.48 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%. As a group, analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current fiscal year.

Insider Transactions at Senseonics Holdings, Inc. Common Stock

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder acquired 13,953 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were acquired at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the purchase, the director directly owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. The trade was a 8.87% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 4.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Integrated Wealth Concepts LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $36,000. Readystate Asset Management LP purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth approximately $574,000. Penn Capital Management Company LLC purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth approximately $535,000. Stonepine Capital Management LLC bought a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at approximately $276,502. Finally, Jefferies Financial Group Inc. bought a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at approximately $102,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing continuous glucose monitoring (CGM) systems for people with diabetes. Its products are designed to measure glucose levels continuously and provide data through a wearable transmitter and mobile application, supporting diabetes management and treatment decisions.

The company’s primary product is the Eversense CGM system, which uses a small sensor implanted under the skin and a removable, rechargeable transmitter worn over the sensor.